BIOMARKERS OF PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY

摘要

Featured are biomarkers for progressive multifocal leukoencephalopathy (PML). Also provided are methods for reducing the occurrence or severity of PML during immunomodulator therapy or identification of PML in an immunocompromised subject.